A search for optimal anesthetic agents for patients with cancer

A search for optimal anesthetic agents for patients with cancer - cancer resection and anesthetic agents

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021231

Enrollment

Registered

2016-02-28

Start date

2016-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

general anesthesia using propofol and remifentanil for cancer resection general anesthesia using propofol, remifentanil and ketamne for cancer resection general anesthesia using sevoflurane and remife

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cancer patients with written informed consent who can understand the aim of the study

Exclusion criteria

Exclusion criteria: Cancer patients who decline the consent of the study

Design outcomes

Primary

Measure	Time frame
The cytotoxic activity of natural killer cells	—

Countries

Japan

Contacts

Public ContactHidetomo Niwa

Hirosaki university hopspital Division of Intensive Care Unit

niwahide@gmail.com0172-39-5022

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026